1,280
Views
0
CrossRef citations to date
0
Altmetric
HPV – Research Article

Effects of a web-based HPV vaccination intervention on cognitive outcomes among young gay, bisexual, and other men who have sex with men

, , , , , , & show all
Article: 2114261 | Received 06 Jul 2022, Accepted 09 Aug 2022, Published online: 07 Sep 2022

References

  • Gillison ML, Chaturvedi AK, Lowy DR. HPV prophylactic vaccines and the potential prevention of noncervical cancers in both men and women. Cancer. 2008;113:1–9.
  • Lacey CJ, Lowndes CM, Shah KV. Chapter 4: burden and management of non-cancerous HPV-related conditions: HPV-6/11 disease. Vaccine. 2006;24:S3/35–41.
  • Smith JS, Gilbert PA, Melendy A, Rana RK, Pimenta JM. Age-specific prevalence of human papillomavirus infection in males: a global review. J Adolesc Health. 2011;48:540–552.
  • Han JJ, Beltran TH, Song JW, Klaric J, Choi YS. Prevalence of genital human papillomavirus infection and human papillomavirus vaccination rates among US adult men: national health and nutrition examination survey (NHANES) 2013-2014. JAMA Oncol. 2017;3:810.
  • Wei F, Gaisa MM, D’Souza G, Xia N, Giuliano AR, Hawes SE, Gao L, Cheng S-H, Donà MG, Goldstone SE, et al. Epidemiology of anal human papillomavirus infection and high-grade squamous intraepithelial lesions in 29 900 men according to HIV status, sexuality, and age: a collaborative pooled analysis of 64 studies. Lancet HIV. 2021;8(9):e531–e543.
  • Clifford GM, Georges D, Shiels MS, Engels EA, Albuquerque A, Poynten IM, Pokomandy A, Easson AM, Stier EA. A meta-analysis of anal cancer incidence by risk group: toward a unified anal cancer risk scale. Int J Cancer. 2021;148:38–47.
  • U.S. Food and Drug Administration. Gardasil 9; 2020. https://www.fda.gov/vaccines-blood-biologics/vaccines/gardasil-9.
  • Meites E, Szilagyi PG, Chesson HW, Unger ER, Romero JR, Markowitz LE. Human papillomavirus vaccination for adults: updated recommendations of the advisory committee on imunization practices. MMWR Morb Mortal Wkly Rep. 2019;68:698–702.
  • Meites E, Kempe A, Markowitz LE. Use of a 2-dose schedule for human papillomavirus vaccination - updated recommendations of the advisory committee on immunization practices. MMWR Morb Mortal Wkly Rep. 2016;65:1405–1408.
  • Nadarzynski T, Frost M, Miller D, Wheldon CW, Wiernik BM, Zou H, Richardson D, Marlow LAV, Smith H, Jones CJ, et al. Vaccine acceptability, uptake and completion amongst men who have sex with men: a systematic review, meta-analysis and theoretical framework. Vaccine. 2021;39(27):3565–3581.
  • Reiter PL, Katz ML, Bauermeister JA, Shoben AB, Paskett ED, McRee AL. Increasing human papillomavirus vaccination among young gay and bisexual men: a randomized pilot trial of the outsmart HPV intervention. LGBT Health. 2018;5:325–329.
  • McRee AL, Shoben A, Bauermeister JA, Katz ML, Paskett ED, Reiter PL. Outsmart HPV: acceptability and short-term effects of a web-based HPV vaccination intervention for young adult gay and bisexual men. Vaccine. 2018;36:8158–8164.
  • Newman PA, Logie CH, Lacombe-Duncan A, Baiden P, Tepjan S, Rubincam C, Doukas N, Asey F. Parents’ uptake of human papillomavirus vaccines for their children: a systematic review and meta-analysis of observational studies. BMJ Open. 2018;8(4): e019206-019206.
  • Radisic G, Chapman J, Flight I, Wilson C. Factors associated with parents’ attitudes to the HPV vaccination of their adolescent sons: a systematic review. Prev Med. 2017;95:26–37.
  • Galbraith KV, Lechuga J, Jenerette CM, Moore LA, Palmer MH, Hamilton JB. Parental acceptance and uptake of the HPV vaccine among African-Americans and Latinos in the United States: a literature review. Soc Sci Med. 2016;159:116–126.
  • Zhou M, Qu S, Zhao L, Campy KS, Wang S. Parental perceptions of human papillomavirus vaccination in central China: the moderating role of socioeconomic factors. Hum Vaccin Immunother. 2019;15:1688–1696.
  • Kessels SJ, Marshall HS, Watson M, Braunack-Mayer AJ, Reuzel R, Tooher RL. Factors associated with HPV vaccine uptake in teenage girls: a systematic review. Vaccine. 2012;30(24):3546–3556. doi:10.1016/j.vaccine.2012.03.063.
  • Santhanes D, Wong CP, Yap YY, San SP, Chaiyakunapruk N, Khan TM. Factors involved in human papillomavirus (HPV) vaccine hesitancy among women in the south-east Asian region (SEAR) and western pacific region (WPR): a scoping review. Hum Vaccin Immunother. 2018;14:124–133.
  • Nadarzynski T, Smith H, Richardson D, Jones CJ, Llewellyn CD. Human papillomavirus and vaccine-related perceptions among men who have sex with men: a systematic review. Sex Transm Infect. 2014;90:515–523.
  • Wheldon CW, Daley EM, Buhi ER, Nyitray AG, Giuliano AR. Health beliefs and attitudes associated with HPV vaccine intention among young gay and bisexual men in the southeastern United States. Vaccine. 2011;29(45):8060–8065. doi:10.1016/j.vaccine.2011.08.045.
  • Reiter PL, McRee AL, Katz ML, Paskett ED. Human papillomavirus vaccination among young adult gay and bisexual men in the United States. Am J Public Health. 2015;105:96–102.
  • Reiter PL, Brewer NT, McRee AL, Gilbert P, Smith JS. Acceptability of HPV vaccine among a national sample of gay and bisexual men. Sex Transm Dis. 2010;37:197–203.
  • Cummings T, Kasting ML, Rosenberger JG, Rosenthal SL, Zimet GD, Stupiansky NW. Catching up or missing out? Human papillomavirus vaccine acceptability among 18- to 26-year-old men who have sex with men in a US national sample. Sex Transm Dis. 2015;42:601–606.
  • Fontenot HB, White BP, Rosenberger JG, Lacasse H, Rutirasiri C, Mayer KH, Zimet G. Mobile app strategy to facilitate human papillomavirus vaccination among young men who have sex with men: pilot intervention study. J Med Internet Res. 2020;22:e22878.
  • Gerend MA, Madkins K, Crosby S, Korpak AK, Phillips GL, Bass M, Houlberg M, Mustanski B. Evaluation of a text messaging-based human papillomavirus vaccination intervention for young sexual minority men: results from a pilot randomized controlled trial. Ann Behav Med. 2021;55:321–332.
  • Reiter PL, Gower AL, Kiss DE, Malone MA, Katz ML, Bauermeister JA, Shoben AB, Paskett ED, McRee A-L. A web-based human papillomavirus vaccination intervention for young gay, bisexual, and other men who have sex with men: protocol for a randomized controlled trial. JMIR Res Protoc. 2020;9:e16294.
  • Rogers RW Cognitive and physiological processes in fear appeals and attitude change: a revised theory of protection motivation. In: Cacioppo J, Petty R, editors. Social psychophysiology: a source book. New York: Guilford Press; 1983. p. 153–176.
  • Fisher JD, Fisher WA. Changing AIDS-risk behavior. Psychol Bull. 1992;111:455–474.
  • Meyer IH. Prejudice, social stress, and mental health in lesbian, gay, and bisexual populations: conceptual issues and research evidence. Psychol Bull. 2003;129:674–697.
  • Gerend MA, Madkins K, Phillips G, 2nd Mustanski B. Predictors of human papillomavirus vaccination among young men who have sex with men. Sex Transm Dis. 2016;43:185–191.
  • Fontenot HB, Fantasia HC, Vetters R, Zimet GD. Increasing HPV vaccination and eliminating barriers: recommendations from young men who have sex with men. Vaccine. 2016;34:6209–6216.
  • Wheldon CW, Daley EM, Walsh-Buhi ER, Baldwin JA, Nyitray AG, Giuliano AR. An integrative theoretical framework for HPV vaccine promotion among male sexual minorities. Am J Mens Health. 2018;12:1409–1420.
  • Centers for Disease Control and Prevention (CDC). Vaccine information statements (VISs) - HPV (human papillomavirus); 2019. https://www.cdc.gov/vaccines/hcp/vis/vis-statements/hpv.html.
  • McRee AL, Brewer NT, Reiter PL, Gottlieb SL, Smith JS. The Carolina HPV immunization attitudes and beliefs scale (CHIAS): scale development and associations with intentions to vaccinate. Sex Transm Dis. 2010;37:234–239.
  • Waller J, Marlow LA, Wardle J. The association between knowledge of HPV and feelings of stigma, shame and anxiety. Sex Transm Infect. 2007;83:155–159.
  • Meidlinger PC, Hope DA. Differentiating disclosure and concealment in measurement of outness for sexual minorities: the Nebraska outness scale. Psychol Sexual Orientation and Gender Divers. 2014;1(4):489–497. doi:10.1037/sgd0000080.
  • Rainbow Health Initiative. Voices of health: a survey of LGBTQ health in minnesota; 2013. http://www.rainbowhealth.org/resources-for-you/research-and-publications/.
  • Norman CD, Skinner HA. eHEALS: The eHealth literacy scale. J Med Internet Res. 2006;8:e27.
  • de Boer MR, Waterlander WE, Kuijper LD, Steenhuis IH, Twisk JW. Testing for baseline differences in randomized controlled trials: an unhealthy research behavior that is hard to eradicate. Int J Behav Nutr Phys Act. 2015;12(1): 4-z.
  • Xi W, Pennell ML, Andridge RR, Paskett ED. Comparison of intent-to-treat analysis strategies for pre-post studies with loss to follow-up. Contemp Clin Trials Commun. 2018;11:20–29.
  • Holm S. A simple sequentially rejective multiple test procedure. Scand J Stat. 1979;6:65–70.
  • Garcia-Retamero R, Cokely ET. Communicating health risks with visual aids. Curr Dir Psychol Sci. 2013;22(5):392–399. doi:10.1177/0963721413491570.
  • Trevena LJ, Zikmund-Fisher BJ, Edwards A, Gaissmaier W, Galesic M, Han PK, King J, Lawson ML, Linder SK, Lipkus I, et al. Presenting quantitative information about decision outcomes: a risk communication primer for patient decision aid developers. BMC Med Inform Decis Mak. 2013;13(Suppl 2): S7-S7.
  • Rimer BK, Glassman B. Is there a use for tailored print communications in cancer risk communication? J Natl Cancer Inst Monogr. 1999;25:140–148.
  • Kreuter MW, Strecher VJ, Glassman B. One size does not fit all: the case for tailoring print materials. Ann Behav Med. 1999;21:276–283.
  • Timmerman GM. Addressing barriers to health promotion in underserved women. Fam Commun Health. 2007;30:34.
  • Malaguti A, Ciocanel O, Sani F, Dillon JF, Eriksen A, Power K. Effectiveness of the use of implementation intentions on reduction of substance use: a meta-analysis. Drug Alcohol Depend. 2020;214:108120.
  • Hagger MS, Luszczynska A. Implementation intention and action planning interventions in health contexts: state of the research and proposals for the way forward. Appl Psychol Health Well Being. 2014;6:1–47.
  • Smulian EA, Mitchell KR, Stokley S. Interventions to increase HPV vaccination coverage: a systematic review. Hum Vaccin Immunother. 2016;12:1566–1588.
  • Gainforth HL, Cao W, Latimer-Cheung AE. Determinants of human papillomavirus (HPV) vaccination intent among three Canadian target groups. J Cancer Educ. 2012;27:717–724.
  • Huang R, Wang Z, Yuan T, Nadarzynski T, Qian H-Z, Li P, Meng X, Wang G, Zhou Y, Luo D, et al. Using protection motivation theory to explain the intention to initiate human papillomavirus vaccination among men who have sex with men in China. Tumour Virus Res. 2021;12:200222.
  • Pew Research Center. Internet/broadband fact sheet; 2021. https://www.pewresearch.org/internet/fact-sheet/internet-broadband/.
  • Pew Research Center. Social media fact sheet; 2021. https://www.pewresearch.org/internet/fact-sheet/social-media/.
  • Teitcher JE, Bockting WO, Bauermeister JA, Hoefer CJ, Miner MH, Klitzman RL. Detecting, preventing, and responding to “fraudsters” in internet research: ethics and tradeoffs. J Law Med Ethics. 2015;43:116–133.